TEL AVIV, Israel--(BUSINESS WIRE)--Yissum, the technology transfer company of the Hebrew University of Jerusalem, introduced today a novel device that enhances the diagnostic value of saliva. Speaking at the Technology Transfer Session at the ILSI Biomed Israel 2008 conference Professor Aaron Palmon, from the Faculty of Dental Medicine at the Hebrew University of Jerusalem, presented a disposable device that clears whole saliva from its major protein constituent – alpha-amylase. The device enables the detection of various low-abundance biomarkers in human saliva.
